AI assistant
Sending…
PFIZER INC — Director's Dealing 2020
Dec 18, 2020
29831_dirs_2020-12-17_299a14fe-e071-45dd-ad30-c5b2ad82b5e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-12-16
Reporting Person: Hwang Angela (Group President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-16 | Common Stock | I | 12970.0000 | $37.8400 | Acquired | 26697.0000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 20241.0000 | Direct |
| Common Stock | 8532.0000 | Indirect |
Footnotes
F1: This transaction constitutes an intra-plan transfer into the Pfizer Inc. stock fund under the Pfizer's Qualified Savings Plan.
F2: The reporting person disclaims beneficial ownership of the shares held by spouse.
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Registration Form
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31